Minrs as modifiers of insulin receptor signaling and methods...

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/68 (2006.01) C12Q 1/00 (2006.01) C12Q 1/02 (2006.01) G01N 33/53 (2006.01) G01N 33/74 (2006.01)

Patent

CA 2473499

Human MINR genes are identified as modulators of INR signaling and thus are therapeutic targets for disorders associated with defective INR signaling. Methods for identifying modulators of MINR, comprising screening for agents that modulate the activity of MINR are provided.

Selon cette invention, des gènes MINR humains sont identifiés en tant que modulateurs de signalisation par les récepteurs de l'insuline et constituent, ainsi, des cibles thérapeutiques dans le traitement de troubles associés à une signalisation par les récepteurs de l'insuline défectueuse. Cette invention concerne également des procédés d'identification de modulateurs de signalisation par les récepteurs de l'insuline, consistant à sélectionner des agents modulant l'activité de signalisation par les récepteurs de l'insuline.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Minrs as modifiers of insulin receptor signaling and methods... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Minrs as modifiers of insulin receptor signaling and methods..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Minrs as modifiers of insulin receptor signaling and methods... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1856369

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.